Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Reading to babies: a surprising boost for tiny hearts and brains?

NCT ID NCT05004857

Knowledge-focused Sponsor: Tulane University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study from Tulane University tests whether a mother reading aloud to her newborn can positively affect the baby's autonomic nervous system. One healthy newborn and mother will have their heart activity measured during reading sessions. The goal is to see if live reading increases vagal tone, a sign of calm and healthy nervous system function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
book reading
What this could lead to
If successful, this could show that reading to newborns has measurable physiological benefits, supporting its use in neonatal care.
What could go wrong
This is a very small pilot study with only one participant, so results may not apply to other babies. It only measures short-term changes, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1 person

The number who actually took part.

Started

Sep 2021

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 minute to 1 week

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Admitted to the Tulane-Lakeside Hospital Newborn Nursery * Corrected gestational age 34 weeks or older * No identified hearing disorder * Do not have a diagnosed developmental disability (i.e. Down Syndrome) * Do not have Fetal Alcohol Syndrome * Medically cleared to participate in the study * Biological mother able/willing to give consent in English \& complete surveys. Exclusion Criteria: * Corrected gestational age \< 34 weeks old * Has an identified or potential hearing disorder (i.e, failed hearing screen) * Has diagnosed developmental disability (i.e. Down syndrome) * Has Fetal Alcohol Syndrome * Is not medically cleared to participate in the study * Biological mother unable/unwilling to give consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autonomic nervous system diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autonomic nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autonomic nervous system diseases

Contacts and locations

Locations

  • Tulane University Health Sciences Center

    New Orleans, Louisiana, 70112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.